Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Claridgeon Nov 07, 2019 4:31pm

108 Views

Post# 30323940

RE:RE:USA

The share price has been in the 0.21$-0.24$ range price since the closing of the pp. And felt in that range before Ph. 2b p#1 and p #2 have been treated. Not after.

So looking at the graph, any link between a drop in the share price because of a potential issue has no ground as the share price has not gone lower since then.

And there's no delay regarding on-boarding of new sites, as per the excerpt Jojomarch posted.

____________________

Thursday, October 31, 2019